Core Model Answers Team

Dr Bruce Green

Bruce is the Founder and CEO of Model Answers. He is passionate about delivering high quality, efficient, and practical solutions to the drug industry and has helped numerous clients successfully work with the FDA, EMA, and PMDA. He has extensive experience in pharmacokinetic and pharmacodynamic analyses, and coupled with his experience as a clinical practitioner and ‘Guest Reviewer’ in the FDA’s Office of Clinical Pharmacology and Biopharmaceutics, leads both science and innovation at Model Answers. He works with a team of highly talented individuals whose work and private attributes reflect his own ideologies. They are entrepreneurial, innovative, and excel across multiple disciplines including science, business management, and communications. Bruce is committed to publishing novel works where possible (click here for more details), and provides training both within and outside the company. You can contact Bruce here. To see Bruce’s full CV, review his LinkedIn profile.

Dr Fran Stringer

Fran is the COO of Model Answers. She has a background in Medicinal Chemistry and Drug Metabolism with over 17 years of experience in drug development at Elan, UCB Pharma and Takeda Pharmaceutical Company. Fran has extensive experience across many therapeutic areas, and has successfully obtained drug approvals from the FDA, EMA and PMDA. She led study design and strategy decision making within clinical pharmacology at Takeda (Europe and Japan) for 9 years, where she implemented innovative modelling and simulation based approaches throughout the drug development process. Fran has published numerous articles on her works (click here for more details), and also provides training within the company.  You can contact Fran here. For a full CV, review her LinkedIn profile.

Dr David McDougall

David is an Associate Director at Model Answers, and leads statistical methodology throughout the company. He has a background in Pharmacy and Statistics, with extensive experience in a range of methodologies and computer languages. David plays a key role in development of the Model Answers Interactive initiative, and has published several articles on his works (click here for more details). David recently completed his PhD studies entitled “How pharmacometrics can assist in the dose individualization of voriconazole for patients with fungal infections”.  For a full CV, review David’s LinkedIn profile.

Professor Stephen Duffull

Stephen Duffull is Professor of Clinical Pharmacy and the Dean of the School of Pharmacy at the University of Otago, Dunedin, New Zealand. He runs a modelling and simulation lab within the School of Pharmacy. He has been involved in the area of PKPD and nonlinear mixed effects modelling for 20 years. For a full CV, review Stephen’s LinkedIn profile.

Dr Steve Choy

Steve is a Pharmacometrician at Model Answers, he has a background in pharmacology and pharmacometrics and recently completed a postdoctoral fellowship at the FDA.  Steve has developed numerous pharmacokinetic,  pharmacodynamic, and systems pharmacology models with a specific focus on diabetes. He completed his PhD at the University of Uppsala under the supervision of Professor Mats Karlsson entitled “Semi-mechanistic models of glucose homeostasis and disease progression in type 2 diabetes”.

Michael Cheng

Mike is an Associate Director at Model Answers, and leads the development of tools that create efficient, high quality, and reproducible numerical materials.  With degrees in both I.T. and Mathematics, he ensures clients get the most out of their data by leading the Model Answers Interactive initiative.  

Dr Allan Rae

Allan is a Pharmacometrician at Model Answers, and leads IT innovation for the company.  His previous experiences implementing machine learning/bioinformatics at Emphron, and developing LyX ensures Model Answers has transparent, validated, reproducible and client friendly deliverables.

Eugene Lau

Eugene is a Scientist at Model Answers and has a background in pharmacology and early preclinical drug development.  He has extensive experience in experimental haematology, molecular and cell biology, protein engineering and development of gene knockout and transgenic animal models.  His previous roles include high-throughput assay development/validation and lead generation at the Translational Research Institute in Brisbane. For a full CV, review Eugene’s LinkedIn profile.

Daniela Sanders

Daniela is the VP of Regulatory Affairs for Medical Devices.  She has worked in the healthcare industry since 1989.  For the past 12 years she has worked as a Senior Regulatory Affairs Specialist in medical devices.  Prior to this she worked as a Safety Evaluator at the FDA (CDER – Office of Drug Safety).  With her medical device and hospital experience as a Clinical Pharmacist and previous roles within drug companies and in research, she has developed advanced skills in written communication with a depth of understanding which has lead to numerous successful regulatory submissions and related correspondence. Daniela provides consulting services to companies of all sizes and experience.  Typical services include:

• Clinical evaluation reports for TGA, CE marking, CFDA
• Medical writing
• Systematic literature reviews
• MDD/MDR Post-Market Surveillance, PMCF 
• CE Marking of Class I to III medical devices
• MDR advice, plans, training
• Australian Medical Device Registrations (400+ to date)
• Regulatory plans for new devices
• Classification
• Advice for start-ups
• Regulatory documentation, editing & review

Dr Wanchana Ungphakorn

Winn is a Pharmacometrician at Model Answers and has a background in clinical pharmacy.  He pursued his PhD at the University of Strathclyde in Glasgow and completed a postdoctoral fellowship at Uppsala University.  Winn has experience in pharmacokinetic-pharmacodynamic modelling of antibacterial drugs and in vitro studies for antibiotics.

Dr Shaun Kumar

Shaun is a Pharmacometrician at Model Answers and has a background in clinical pharmacology and pharmacometrics.  He completed his PhD at UNSW Australia (PI: Richard Day), followed by a postdoctoral fellowship in paediatric clinical pharmacology at the University of Utah (PI: Catherine Sherwin).  Shaun has experience in pharmacokinetic modelling of a range of molecules and has experience with using electronic health records as a data source.

Dr Graham Scott

Graham works as a consultant to Model Answers.  He is a pharmacist with more than 30 years’ experience in the pharmaceutical industry, having worked in various roles in preclinical, early clinical development and clinical pharmacology. His work experience has been with Inveresk Research, Pharmacia & Upjohn, Novartis, Takeda and Certara.

For a full CV, review his LinkedIn profile.